Hanmi, Pharmaceutical

Hanmi Pharmaceutical and Beijing Hanmi Progress Clinical Trials of Co-developed BH3120 as a Next-Generation Cancer Immunotherapy

Published on 08/07/2025 at 18:06 | prnewswire.co.uk

Hanmi Pharmaceutical Texas South Korea New Jersey California

View original content:https://www.prnewswire.co.uk/news-releases/hanmi-pharmaceutical-and-beijing-hanmi-progress-clinical-trials-of-co-developed-bh3120-as-a-next-generation-cancer-immunotherapy-302314974.html

en | boerse | 67952371 |